English

    Overview

  • Dr. Manish Sharma is a well-known doctor in the field of oncology. A beloved healthcare professional, he balances his state-of-the-art clinical skills with deep-mindedness toward patients. A career spanning over 20 years of patient care, with more than half that time dedicated to the domain of cancer therapy, has shaped him into one who combines an unusual set of skills with dogged determination to improve the quality of life of cancer patients. Currently, Dr. Sharma holds the position of Senior Consultant in Medical Oncology at Manipal Hospital, Delhi; he is reputed to be able to integrate state-of-the-art treatments with hands-on care, nurturing each patient with care.

  • His medical journey began at PGIMS, Rohtak, where he completed his graduation in medicine, followed by a DNB in Medicine from Safdarjung Hospital, New Delhi. His change of concentration to the field of cancer fuelled him towards super-specialisation in Medical Oncology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC), Delhi. He was awarded the coveted President NBE Super-Speciality Gold Medal, which goes to show that, apart from academic brilliance, he was dedicated to changing the fate of oncology care.

  • He has also held numerous prestigious leadership positions that have contributed to shaping his professional career as well as served numerous patients. As Consultant and Head of Unit, Medical Oncology at Action Cancer Hospital, Paschim Vihar, Delhi, and earlier as Consultant in Medical Oncology at RGCI&RC, he has played a leading role in defining cancer treatment protocols, mentoring younger doctors, and implementing new therapies. His work has spanned the management of solid tumours—including breast, lung, gastrointestinal, and genitourinary cancers—as well as haematological malignancies such as leukaemia, lymphoma, and myeloma. Whether it is targeted therapy, immuno‑oncology, or precision medicine, Dr. Sharma is adept at designing treatment plans that are uniquely tailored to the medical and emotional needs of each individual.

    • Field of Expertise

  • Chemotherapies
  • Immunotherapies
  • Targetted Theries
  • Precision Medicine
  • Hormonal Therapies
  • All Types Of Solid Tumours And Haematological Malignancies
  • Preventive And Palliative Care

    • Fellowship & Membership

  • ASCO
  • ESMO
  • ISMPO
  • Preceptorship program on early breast cancer organised by Peter MacCallum center Melbourne, Australia.
  • Lung cancer preceptorship organised by Peter MacCallum Centre Melbourne, Australia.
  • Preceptorship course on immunoncology organised by ESMO. Singapore.
  • Receptorship course in immunooncology organised by ESMO. Singapore.
  • Advanced course in clinical questions in prostate cancer organised by ESMO. Singapore.
  • Preceptorship programme in NSCLC organised by ESMO. Singapore.
  • Medical Council of India, registration number 26551.

    • Languages Spoken

  • English
  • Hindi
  • Punjabi

    • Awards & Achievements

  • President NBE gold medal award in medical oncology.
  • ANBAI Super Speciality Gold Medal Award 2017.

    • Talks & Publications

  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: prospective study from cancer centre in northern- submitted and accepted by National Board Examinations (2015-2018).
  • Clinical and epidemiological profile of elderly Hodgkin's lymphoma in India. Cureus July 2022.
  • Epidemiological, clinical and treatment outcome of stage 4 nonsquamous non-small cell lung cancer patients presenting to a tertiary care hospital in North India. Oncology Journal of India Dec 2021.
  • Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian Journal of Oncology 2022.
  • Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre. Indian Journal of Cancer 2018.
  • Sharma M. Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: a prospective study from a cancer centre in northern. South Asian Journal of Oncology 2019.
  • Suri J.C., Sharma M, Kampani G., Sen M.K. Prevalence and profile of sleep disordered breathing amongst patients with congestive heart failure: Indian Journal Sleep Medicine 2010;5:120-127.
  • Neoadjuvant Chemotherapy (Preoperative chemotherapy) or Induction chemotherapy (sequential chemoradiotherapy) in very locally advanced unresectable primary or second primary head and neck cancer: Robert Louis. A, Sharma M, Agarwal M, Gupta S. K, Bajaj R. presented at the Asian Clinical Oncology Society International Conference 2016.
  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer.
  • Batra U, Goyal P., Sharma M, Aggarwal M, Jain P, Bajaj R. P3.02b-069 To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India. Journal of Thoracic Oncology 2017;12:S1232.
  • Sharma A, Doval D.C, Dutta K, Bajaj R, Sharma M, Jain P. 119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India. Annals of Oncology. 2016;27mdw577.003.
  • M Sharma, P-063. Role of maintenance gemcitabine in advanced and metastatic carcinoma gall bladder, Annals of Oncology, Volume 30, Issue Supplement_4, July 2019, mdz155.062, https://doi.org/10.1093/annonc/mdz155.062.
  • 377P NGS in advanced NSCLC in a developing country: Ready for prime time? Annals of Oncology30(Supplement_9).DOI:10.1093/annonc/mdz418.007 44P Correlation of circulating tumour cells with PET-CT in metastatic breast cancer.
  • 247PRole of ADC values in assessing response after chemoradiotherapy in cervical cancer and in identifying residual disease. November 2019. Annals of Oncology 30 (Supplement_9).DOI:10.1093/annonc/mdz426.02.
  • 117P Correlation of MRI-derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas: November 2019: Annals of Oncology 30 (Supplement_7): DOI:10.1093/annonc/mdz413.121.
  • Maheshwari U, Koyyala V. P. B, Goyal S, Rajpurohit S, Sharma M, Jajodia A.Application of next-generation sequencing to detect targetable mutation: A case report of good response to everolimus in salivary ductal carcinoma. International Journal of Medical and Health Research. 2018;4:153-155.
  • Agrawal C, Sharma M, Singh A, Goyal V, Talwar V. Isolated splenic metastasis in a case of carcinoma jejunum. Indian Journal of Medical and Pediatric Oncology 2018 Accepted and ahead of print.
  • Sharma M. Rare case of non-small cell lung cancer with intracardiac metastasis.Accepted for print in the Indian Journal of Cardiology.
  • SharmaM. Primary squamous cell carcinoma of the stomach. 2018. Asian journal of oncology.
  • Sharma M. Excellent Outcome in a Patient with Choriocarcinoma with Spinal Metastasis with Cord Compression: September 2019:DOI:10.1007/s40944-019-0319-9.
  • Palliative chemotherapy in elderly patients with comorbidities: is it a paradox: May2019:Indian Journal of Palliative Care
  • A rare case of pinealoblastoma in an adult with complete response to treatment: October 2018: South Asian Journal of Cancer 7(4):262: DOI:10.4103/sajc.sajc_262_18.

    Fellowship & Membership

  • ASCO
  • ESMO
  • ISMPO
  • Preceptorship program on early breast cancer organised by Peter MacCallum center Melbourne, Australia.
  • Lung cancer preceptorship organised by Peter MacCallum Centre Melbourne, Australia.
  • Preceptorship course on immunoncology organised by ESMO. Singapore.
  • Receptorship course in immunooncology organised by ESMO. Singapore.
  • Advanced course in clinical questions in prostate cancer organised by ESMO. Singapore.
  • Preceptorship programme in NSCLC organised by ESMO. Singapore.
  • Medical Council of India, registration number 26551.

    • Overview

  • Dr. Manish Sharma is a well-known doctor in the field of oncology. A beloved healthcare professional, he balances his state-of-the-art clinical skills with deep-mindedness toward patients. A career spanning over 20 years of patient care, with more than half that time dedicated to the domain of cancer therapy, has shaped him into one who combines an unusual set of skills with dogged determination to improve the quality of life of cancer patients. Currently, Dr. Sharma holds the position of Senior Consultant in Medical Oncology at Manipal Hospital, Delhi; he is reputed to be able to integrate state-of-the-art treatments with hands-on care, nurturing each patient with care.

  • His medical journey began at PGIMS, Rohtak, where he completed his graduation in medicine, followed by a DNB in Medicine from Safdarjung Hospital, New Delhi. His change of concentration to the field of cancer fuelled him towards super-specialisation in Medical Oncology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC), Delhi. He was awarded the coveted President NBE Super-Speciality Gold Medal, which goes to show that, apart from academic brilliance, he was dedicated to changing the fate of oncology care.

  • He has also held numerous prestigious leadership positions that have contributed to shaping his professional career as well as served numerous patients. As Consultant and Head of Unit, Medical Oncology at Action Cancer Hospital, Paschim Vihar, Delhi, and earlier as Consultant in Medical Oncology at RGCI&RC, he has played a leading role in defining cancer treatment protocols, mentoring younger doctors, and implementing new therapies. His work has spanned the management of solid tumours—including breast, lung, gastrointestinal, and genitourinary cancers—as well as haematological malignancies such as leukaemia, lymphoma, and myeloma. Whether it is targeted therapy, immuno‑oncology, or precision medicine, Dr. Sharma is adept at designing treatment plans that are uniquely tailored to the medical and emotional needs of each individual.

    • Field of Expertise

  • Chemotherapies
  • Immunotherapies
  • Targetted Theries
  • Precision Medicine
  • Hormonal Therapies
  • All Types Of Solid Tumours And Haematological Malignancies
  • Preventive And Palliative Care

    • Languages Spoken

  • English
  • Hindi
  • Punjabi

    • Awards & Achievements

  • President NBE gold medal award in medical oncology.
  • ANBAI Super Speciality Gold Medal Award 2017.

    • Talks & Publications

  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: prospective study from cancer centre in northern- submitted and accepted by National Board Examinations (2015-2018).
  • Clinical and epidemiological profile of elderly Hodgkin's lymphoma in India. Cureus July 2022.
  • Epidemiological, clinical and treatment outcome of stage 4 nonsquamous non-small cell lung cancer patients presenting to a tertiary care hospital in North India. Oncology Journal of India Dec 2021.
  • Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian Journal of Oncology 2022.
  • Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre. Indian Journal of Cancer 2018.
  • Sharma M. Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: a prospective study from a cancer centre in northern. South Asian Journal of Oncology 2019.
  • Suri J.C., Sharma M, Kampani G., Sen M.K. Prevalence and profile of sleep disordered breathing amongst patients with congestive heart failure: Indian Journal Sleep Medicine 2010;5:120-127.
  • Neoadjuvant Chemotherapy (Preoperative chemotherapy) or Induction chemotherapy (sequential chemoradiotherapy) in very locally advanced unresectable primary or second primary head and neck cancer: Robert Louis. A, Sharma M, Agarwal M, Gupta S. K, Bajaj R. presented at the Asian Clinical Oncology Society International Conference 2016.
  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer.
  • Batra U, Goyal P., Sharma M, Aggarwal M, Jain P, Bajaj R. P3.02b-069 To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India. Journal of Thoracic Oncology 2017;12:S1232.
  • Sharma A, Doval D.C, Dutta K, Bajaj R, Sharma M, Jain P. 119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India. Annals of Oncology. 2016;27mdw577.003.
  • M Sharma, P-063. Role of maintenance gemcitabine in advanced and metastatic carcinoma gall bladder, Annals of Oncology, Volume 30, Issue Supplement_4, July 2019, mdz155.062, https://doi.org/10.1093/annonc/mdz155.062.
  • 377P NGS in advanced NSCLC in a developing country: Ready for prime time? Annals of Oncology30(Supplement_9).DOI:10.1093/annonc/mdz418.007 44P Correlation of circulating tumour cells with PET-CT in metastatic breast cancer.
  • 247PRole of ADC values in assessing response after chemoradiotherapy in cervical cancer and in identifying residual disease. November 2019. Annals of Oncology 30 (Supplement_9).DOI:10.1093/annonc/mdz426.02.
  • 117P Correlation of MRI-derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas: November 2019: Annals of Oncology 30 (Supplement_7): DOI:10.1093/annonc/mdz413.121.
  • Maheshwari U, Koyyala V. P. B, Goyal S, Rajpurohit S, Sharma M, Jajodia A.Application of next-generation sequencing to detect targetable mutation: A case report of good response to everolimus in salivary ductal carcinoma. International Journal of Medical and Health Research. 2018;4:153-155.
  • Agrawal C, Sharma M, Singh A, Goyal V, Talwar V. Isolated splenic metastasis in a case of carcinoma jejunum. Indian Journal of Medical and Pediatric Oncology 2018 Accepted and ahead of print.
  • Sharma M. Rare case of non-small cell lung cancer with intracardiac metastasis.Accepted for print in the Indian Journal of Cardiology.
  • SharmaM. Primary squamous cell carcinoma of the stomach. 2018. Asian journal of oncology.
  • Sharma M. Excellent Outcome in a Patient with Choriocarcinoma with Spinal Metastasis with Cord Compression: September 2019:DOI:10.1007/s40944-019-0319-9.
  • Palliative chemotherapy in elderly patients with comorbidities: is it a paradox: May2019:Indian Journal of Palliative Care
  • A rare case of pinealoblastoma in an adult with complete response to treatment: October 2018: South Asian Journal of Cancer 7(4):262: DOI:10.4103/sajc.sajc_262_18.

    Languages Spoken

  • English
  • Hindi
  • Punjabi

    • Overview

  • Dr. Manish Sharma is a well-known doctor in the field of oncology. A beloved healthcare professional, he balances his state-of-the-art clinical skills with deep-mindedness toward patients. A career spanning over 20 years of patient care, with more than half that time dedicated to the domain of cancer therapy, has shaped him into one who combines an unusual set of skills with dogged determination to improve the quality of life of cancer patients. Currently, Dr. Sharma holds the position of Senior Consultant in Medical Oncology at Manipal Hospital, Delhi; he is reputed to be able to integrate state-of-the-art treatments with hands-on care, nurturing each patient with care.

  • His medical journey began at PGIMS, Rohtak, where he completed his graduation in medicine, followed by a DNB in Medicine from Safdarjung Hospital, New Delhi. His change of concentration to the field of cancer fuelled him towards super-specialisation in Medical Oncology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC), Delhi. He was awarded the coveted President NBE Super-Speciality Gold Medal, which goes to show that, apart from academic brilliance, he was dedicated to changing the fate of oncology care.

  • He has also held numerous prestigious leadership positions that have contributed to shaping his professional career as well as served numerous patients. As Consultant and Head of Unit, Medical Oncology at Action Cancer Hospital, Paschim Vihar, Delhi, and earlier as Consultant in Medical Oncology at RGCI&RC, he has played a leading role in defining cancer treatment protocols, mentoring younger doctors, and implementing new therapies. His work has spanned the management of solid tumours—including breast, lung, gastrointestinal, and genitourinary cancers—as well as haematological malignancies such as leukaemia, lymphoma, and myeloma. Whether it is targeted therapy, immuno‑oncology, or precision medicine, Dr. Sharma is adept at designing treatment plans that are uniquely tailored to the medical and emotional needs of each individual.

    • Fellowship & Membership

  • ASCO
  • ESMO
  • ISMPO
  • Preceptorship program on early breast cancer organised by Peter MacCallum center Melbourne, Australia.
  • Lung cancer preceptorship organised by Peter MacCallum Centre Melbourne, Australia.
  • Preceptorship course on immunoncology organised by ESMO. Singapore.
  • Receptorship course in immunooncology organised by ESMO. Singapore.
  • Advanced course in clinical questions in prostate cancer organised by ESMO. Singapore.
  • Preceptorship programme in NSCLC organised by ESMO. Singapore.
  • Medical Council of India, registration number 26551.

    • Field of Expertise

  • Chemotherapies
  • Immunotherapies
  • Targetted Theries
  • Precision Medicine
  • Hormonal Therapies
  • All Types Of Solid Tumours And Haematological Malignancies
  • Preventive And Palliative Care

    • Awards & Achievements

  • President NBE gold medal award in medical oncology.
  • ANBAI Super Speciality Gold Medal Award 2017.

    • Talks & Publications

  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: prospective study from cancer centre in northern- submitted and accepted by National Board Examinations (2015-2018).
  • Clinical and epidemiological profile of elderly Hodgkin's lymphoma in India. Cureus July 2022.
  • Epidemiological, clinical and treatment outcome of stage 4 nonsquamous non-small cell lung cancer patients presenting to a tertiary care hospital in North India. Oncology Journal of India Dec 2021.
  • Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian Journal of Oncology 2022.
  • Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre. Indian Journal of Cancer 2018.
  • Sharma M. Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: a prospective study from a cancer centre in northern. South Asian Journal of Oncology 2019.
  • Suri J.C., Sharma M, Kampani G., Sen M.K. Prevalence and profile of sleep disordered breathing amongst patients with congestive heart failure: Indian Journal Sleep Medicine 2010;5:120-127.
  • Neoadjuvant Chemotherapy (Preoperative chemotherapy) or Induction chemotherapy (sequential chemoradiotherapy) in very locally advanced unresectable primary or second primary head and neck cancer: Robert Louis. A, Sharma M, Agarwal M, Gupta S. K, Bajaj R. presented at the Asian Clinical Oncology Society International Conference 2016.
  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer.
  • Batra U, Goyal P., Sharma M, Aggarwal M, Jain P, Bajaj R. P3.02b-069 To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India. Journal of Thoracic Oncology 2017;12:S1232.
  • Sharma A, Doval D.C, Dutta K, Bajaj R, Sharma M, Jain P. 119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India. Annals of Oncology. 2016;27mdw577.003.
  • M Sharma, P-063. Role of maintenance gemcitabine in advanced and metastatic carcinoma gall bladder, Annals of Oncology, Volume 30, Issue Supplement_4, July 2019, mdz155.062, https://doi.org/10.1093/annonc/mdz155.062.
  • 377P NGS in advanced NSCLC in a developing country: Ready for prime time? Annals of Oncology30(Supplement_9).DOI:10.1093/annonc/mdz418.007 44P Correlation of circulating tumour cells with PET-CT in metastatic breast cancer.
  • 247PRole of ADC values in assessing response after chemoradiotherapy in cervical cancer and in identifying residual disease. November 2019. Annals of Oncology 30 (Supplement_9).DOI:10.1093/annonc/mdz426.02.
  • 117P Correlation of MRI-derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas: November 2019: Annals of Oncology 30 (Supplement_7): DOI:10.1093/annonc/mdz413.121.
  • Maheshwari U, Koyyala V. P. B, Goyal S, Rajpurohit S, Sharma M, Jajodia A.Application of next-generation sequencing to detect targetable mutation: A case report of good response to everolimus in salivary ductal carcinoma. International Journal of Medical and Health Research. 2018;4:153-155.
  • Agrawal C, Sharma M, Singh A, Goyal V, Talwar V. Isolated splenic metastasis in a case of carcinoma jejunum. Indian Journal of Medical and Pediatric Oncology 2018 Accepted and ahead of print.
  • Sharma M. Rare case of non-small cell lung cancer with intracardiac metastasis.Accepted for print in the Indian Journal of Cardiology.
  • SharmaM. Primary squamous cell carcinoma of the stomach. 2018. Asian journal of oncology.
  • Sharma M. Excellent Outcome in a Patient with Choriocarcinoma with Spinal Metastasis with Cord Compression: September 2019:DOI:10.1007/s40944-019-0319-9.
  • Palliative chemotherapy in elderly patients with comorbidities: is it a paradox: May2019:Indian Journal of Palliative Care
  • A rare case of pinealoblastoma in an adult with complete response to treatment: October 2018: South Asian Journal of Cancer 7(4):262: DOI:10.4103/sajc.sajc_262_18.

    Field of Expertise

  • Chemotherapies
  • Immunotherapies
  • Targetted Theries
  • Precision Medicine
  • Hormonal Therapies
  • All Types Of Solid Tumours And Haematological Malignancies
  • Preventive And Palliative Care

    • Fellowship & Membership

  • ASCO
  • ESMO
  • ISMPO
  • Preceptorship program on early breast cancer organised by Peter MacCallum center Melbourne, Australia.
  • Lung cancer preceptorship organised by Peter MacCallum Centre Melbourne, Australia.
  • Preceptorship course on immunoncology organised by ESMO. Singapore.
  • Receptorship course in immunooncology organised by ESMO. Singapore.
  • Advanced course in clinical questions in prostate cancer organised by ESMO. Singapore.
  • Preceptorship programme in NSCLC organised by ESMO. Singapore.
  • Medical Council of India, registration number 26551.

    • Languages Spoken

  • English
  • Hindi
  • Punjabi

    • Awards & Achievements

  • President NBE gold medal award in medical oncology.
  • ANBAI Super Speciality Gold Medal Award 2017.

    • Talks & Publications

  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: prospective study from cancer centre in northern- submitted and accepted by National Board Examinations (2015-2018).
  • Clinical and epidemiological profile of elderly Hodgkin's lymphoma in India. Cureus July 2022.
  • Epidemiological, clinical and treatment outcome of stage 4 nonsquamous non-small cell lung cancer patients presenting to a tertiary care hospital in North India. Oncology Journal of India Dec 2021.
  • Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian Journal of Oncology 2022.
  • Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre. Indian Journal of Cancer 2018.
  • Sharma M. Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: a prospective study from a cancer centre in northern. South Asian Journal of Oncology 2019.
  • Suri J.C., Sharma M, Kampani G., Sen M.K. Prevalence and profile of sleep disordered breathing amongst patients with congestive heart failure: Indian Journal Sleep Medicine 2010;5:120-127.
  • Neoadjuvant Chemotherapy (Preoperative chemotherapy) or Induction chemotherapy (sequential chemoradiotherapy) in very locally advanced unresectable primary or second primary head and neck cancer: Robert Louis. A, Sharma M, Agarwal M, Gupta S. K, Bajaj R. presented at the Asian Clinical Oncology Society International Conference 2016.
  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer.
  • Batra U, Goyal P., Sharma M, Aggarwal M, Jain P, Bajaj R. P3.02b-069 To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India. Journal of Thoracic Oncology 2017;12:S1232.
  • Sharma A, Doval D.C, Dutta K, Bajaj R, Sharma M, Jain P. 119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India. Annals of Oncology. 2016;27mdw577.003.
  • M Sharma, P-063. Role of maintenance gemcitabine in advanced and metastatic carcinoma gall bladder, Annals of Oncology, Volume 30, Issue Supplement_4, July 2019, mdz155.062, https://doi.org/10.1093/annonc/mdz155.062.
  • 377P NGS in advanced NSCLC in a developing country: Ready for prime time? Annals of Oncology30(Supplement_9).DOI:10.1093/annonc/mdz418.007 44P Correlation of circulating tumour cells with PET-CT in metastatic breast cancer.
  • 247PRole of ADC values in assessing response after chemoradiotherapy in cervical cancer and in identifying residual disease. November 2019. Annals of Oncology 30 (Supplement_9).DOI:10.1093/annonc/mdz426.02.
  • 117P Correlation of MRI-derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas: November 2019: Annals of Oncology 30 (Supplement_7): DOI:10.1093/annonc/mdz413.121.
  • Maheshwari U, Koyyala V. P. B, Goyal S, Rajpurohit S, Sharma M, Jajodia A.Application of next-generation sequencing to detect targetable mutation: A case report of good response to everolimus in salivary ductal carcinoma. International Journal of Medical and Health Research. 2018;4:153-155.
  • Agrawal C, Sharma M, Singh A, Goyal V, Talwar V. Isolated splenic metastasis in a case of carcinoma jejunum. Indian Journal of Medical and Pediatric Oncology 2018 Accepted and ahead of print.
  • Sharma M. Rare case of non-small cell lung cancer with intracardiac metastasis.Accepted for print in the Indian Journal of Cardiology.
  • SharmaM. Primary squamous cell carcinoma of the stomach. 2018. Asian journal of oncology.
  • Sharma M. Excellent Outcome in a Patient with Choriocarcinoma with Spinal Metastasis with Cord Compression: September 2019:DOI:10.1007/s40944-019-0319-9.
  • Palliative chemotherapy in elderly patients with comorbidities: is it a paradox: May2019:Indian Journal of Palliative Care
  • A rare case of pinealoblastoma in an adult with complete response to treatment: October 2018: South Asian Journal of Cancer 7(4):262: DOI:10.4103/sajc.sajc_262_18.

    • Overview

  • Dr. Manish Sharma is a well-known doctor in the field of oncology. A beloved healthcare professional, he balances his state-of-the-art clinical skills with deep-mindedness toward patients. A career spanning over 20 years of patient care, with more than half that time dedicated to the domain of cancer therapy, has shaped him into one who combines an unusual set of skills with dogged determination to improve the quality of life of cancer patients. Currently, Dr. Sharma holds the position of Senior Consultant in Medical Oncology at Manipal Hospital, Delhi; he is reputed to be able to integrate state-of-the-art treatments with hands-on care, nurturing each patient with care.

  • His medical journey began at PGIMS, Rohtak, where he completed his graduation in medicine, followed by a DNB in Medicine from Safdarjung Hospital, New Delhi. His change of concentration to the field of cancer fuelled him towards super-specialisation in Medical Oncology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC), Delhi. He was awarded the coveted President NBE Super-Speciality Gold Medal, which goes to show that, apart from academic brilliance, he was dedicated to changing the fate of oncology care.

  • He has also held numerous prestigious leadership positions that have contributed to shaping his professional career as well as served numerous patients. As Consultant and Head of Unit, Medical Oncology at Action Cancer Hospital, Paschim Vihar, Delhi, and earlier as Consultant in Medical Oncology at RGCI&RC, he has played a leading role in defining cancer treatment protocols, mentoring younger doctors, and implementing new therapies. His work has spanned the management of solid tumours—including breast, lung, gastrointestinal, and genitourinary cancers—as well as haematological malignancies such as leukaemia, lymphoma, and myeloma. Whether it is targeted therapy, immuno‑oncology, or precision medicine, Dr. Sharma is adept at designing treatment plans that are uniquely tailored to the medical and emotional needs of each individual.

    Awards & Achievements

  • President NBE gold medal award in medical oncology.
  • ANBAI Super Speciality Gold Medal Award 2017.

    • Fellowship & Membership

  • ASCO
  • ESMO
  • ISMPO
  • Preceptorship program on early breast cancer organised by Peter MacCallum center Melbourne, Australia.
  • Lung cancer preceptorship organised by Peter MacCallum Centre Melbourne, Australia.
  • Preceptorship course on immunoncology organised by ESMO. Singapore.
  • Receptorship course in immunooncology organised by ESMO. Singapore.
  • Advanced course in clinical questions in prostate cancer organised by ESMO. Singapore.
  • Preceptorship programme in NSCLC organised by ESMO. Singapore.
  • Medical Council of India, registration number 26551.

    • Field of Expertise

  • Chemotherapies
  • Immunotherapies
  • Targetted Theries
  • Precision Medicine
  • Hormonal Therapies
  • All Types Of Solid Tumours And Haematological Malignancies
  • Preventive And Palliative Care

    • Languages Spoken

  • English
  • Hindi
  • Punjabi

    • Talks & Publications

  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: prospective study from cancer centre in northern- submitted and accepted by National Board Examinations (2015-2018).
  • Clinical and epidemiological profile of elderly Hodgkin's lymphoma in India. Cureus July 2022.
  • Epidemiological, clinical and treatment outcome of stage 4 nonsquamous non-small cell lung cancer patients presenting to a tertiary care hospital in North India. Oncology Journal of India Dec 2021.
  • Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian Journal of Oncology 2022.
  • Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre. Indian Journal of Cancer 2018.
  • Sharma M. Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: a prospective study from a cancer centre in northern. South Asian Journal of Oncology 2019.
  • Suri J.C., Sharma M, Kampani G., Sen M.K. Prevalence and profile of sleep disordered breathing amongst patients with congestive heart failure: Indian Journal Sleep Medicine 2010;5:120-127.
  • Neoadjuvant Chemotherapy (Preoperative chemotherapy) or Induction chemotherapy (sequential chemoradiotherapy) in very locally advanced unresectable primary or second primary head and neck cancer: Robert Louis. A, Sharma M, Agarwal M, Gupta S. K, Bajaj R. presented at the Asian Clinical Oncology Society International Conference 2016.
  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer.
  • Batra U, Goyal P., Sharma M, Aggarwal M, Jain P, Bajaj R. P3.02b-069 To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India. Journal of Thoracic Oncology 2017;12:S1232.
  • Sharma A, Doval D.C, Dutta K, Bajaj R, Sharma M, Jain P. 119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India. Annals of Oncology. 2016;27mdw577.003.
  • M Sharma, P-063. Role of maintenance gemcitabine in advanced and metastatic carcinoma gall bladder, Annals of Oncology, Volume 30, Issue Supplement_4, July 2019, mdz155.062, https://doi.org/10.1093/annonc/mdz155.062.
  • 377P NGS in advanced NSCLC in a developing country: Ready for prime time? Annals of Oncology30(Supplement_9).DOI:10.1093/annonc/mdz418.007 44P Correlation of circulating tumour cells with PET-CT in metastatic breast cancer.
  • 247PRole of ADC values in assessing response after chemoradiotherapy in cervical cancer and in identifying residual disease. November 2019. Annals of Oncology 30 (Supplement_9).DOI:10.1093/annonc/mdz426.02.
  • 117P Correlation of MRI-derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas: November 2019: Annals of Oncology 30 (Supplement_7): DOI:10.1093/annonc/mdz413.121.
  • Maheshwari U, Koyyala V. P. B, Goyal S, Rajpurohit S, Sharma M, Jajodia A.Application of next-generation sequencing to detect targetable mutation: A case report of good response to everolimus in salivary ductal carcinoma. International Journal of Medical and Health Research. 2018;4:153-155.
  • Agrawal C, Sharma M, Singh A, Goyal V, Talwar V. Isolated splenic metastasis in a case of carcinoma jejunum. Indian Journal of Medical and Pediatric Oncology 2018 Accepted and ahead of print.
  • Sharma M. Rare case of non-small cell lung cancer with intracardiac metastasis.Accepted for print in the Indian Journal of Cardiology.
  • SharmaM. Primary squamous cell carcinoma of the stomach. 2018. Asian journal of oncology.
  • Sharma M. Excellent Outcome in a Patient with Choriocarcinoma with Spinal Metastasis with Cord Compression: September 2019:DOI:10.1007/s40944-019-0319-9.
  • Palliative chemotherapy in elderly patients with comorbidities: is it a paradox: May2019:Indian Journal of Palliative Care
  • A rare case of pinealoblastoma in an adult with complete response to treatment: October 2018: South Asian Journal of Cancer 7(4):262: DOI:10.4103/sajc.sajc_262_18.

    • Overview

  • Dr. Manish Sharma is a well-known doctor in the field of oncology. A beloved healthcare professional, he balances his state-of-the-art clinical skills with deep-mindedness toward patients. A career spanning over 20 years of patient care, with more than half that time dedicated to the domain of cancer therapy, has shaped him into one who combines an unusual set of skills with dogged determination to improve the quality of life of cancer patients. Currently, Dr. Sharma holds the position of Senior Consultant in Medical Oncology at Manipal Hospital, Delhi; he is reputed to be able to integrate state-of-the-art treatments with hands-on care, nurturing each patient with care.

  • His medical journey began at PGIMS, Rohtak, where he completed his graduation in medicine, followed by a DNB in Medicine from Safdarjung Hospital, New Delhi. His change of concentration to the field of cancer fuelled him towards super-specialisation in Medical Oncology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC), Delhi. He was awarded the coveted President NBE Super-Speciality Gold Medal, which goes to show that, apart from academic brilliance, he was dedicated to changing the fate of oncology care.

  • He has also held numerous prestigious leadership positions that have contributed to shaping his professional career as well as served numerous patients. As Consultant and Head of Unit, Medical Oncology at Action Cancer Hospital, Paschim Vihar, Delhi, and earlier as Consultant in Medical Oncology at RGCI&RC, he has played a leading role in defining cancer treatment protocols, mentoring younger doctors, and implementing new therapies. His work has spanned the management of solid tumours—including breast, lung, gastrointestinal, and genitourinary cancers—as well as haematological malignancies such as leukaemia, lymphoma, and myeloma. Whether it is targeted therapy, immuno‑oncology, or precision medicine, Dr. Sharma is adept at designing treatment plans that are uniquely tailored to the medical and emotional needs of each individual.

    Talks & Publications

  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: prospective study from cancer centre in northern- submitted and accepted by National Board Examinations (2015-2018).
  • Clinical and epidemiological profile of elderly Hodgkin's lymphoma in India. Cureus July 2022.
  • Epidemiological, clinical and treatment outcome of stage 4 nonsquamous non-small cell lung cancer patients presenting to a tertiary care hospital in North India. Oncology Journal of India Dec 2021.
  • Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian Journal of Oncology 2022.
  • Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre. Indian Journal of Cancer 2018.
  • Sharma M. Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer: a prospective study from a cancer centre in northern. South Asian Journal of Oncology 2019.
  • Suri J.C., Sharma M, Kampani G., Sen M.K. Prevalence and profile of sleep disordered breathing amongst patients with congestive heart failure: Indian Journal Sleep Medicine 2010;5:120-127.
  • Neoadjuvant Chemotherapy (Preoperative chemotherapy) or Induction chemotherapy (sequential chemoradiotherapy) in very locally advanced unresectable primary or second primary head and neck cancer: Robert Louis. A, Sharma M, Agarwal M, Gupta S. K, Bajaj R. presented at the Asian Clinical Oncology Society International Conference 2016.
  • Role of maintenance gemcitabine in metastatic/unresectable gall bladder cancer.
  • Batra U, Goyal P., Sharma M, Aggarwal M, Jain P, Bajaj R. P3.02b-069 To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India. Journal of Thoracic Oncology 2017;12:S1232.
  • Sharma A, Doval D.C, Dutta K, Bajaj R, Sharma M, Jain P. 119P Efficacy and safety profile of eribulin mesylate in advanced breast cancer: Single-centre experience from India. Annals of Oncology. 2016;27mdw577.003.
  • M Sharma, P-063. Role of maintenance gemcitabine in advanced and metastatic carcinoma gall bladder, Annals of Oncology, Volume 30, Issue Supplement_4, July 2019, mdz155.062, https://doi.org/10.1093/annonc/mdz155.062.
  • 377P NGS in advanced NSCLC in a developing country: Ready for prime time? Annals of Oncology30(Supplement_9).DOI:10.1093/annonc/mdz418.007 44P Correlation of circulating tumour cells with PET-CT in metastatic breast cancer.
  • 247PRole of ADC values in assessing response after chemoradiotherapy in cervical cancer and in identifying residual disease. November 2019. Annals of Oncology 30 (Supplement_9).DOI:10.1093/annonc/mdz426.02.
  • 117P Correlation of MRI-derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas: November 2019: Annals of Oncology 30 (Supplement_7): DOI:10.1093/annonc/mdz413.121.
  • Maheshwari U, Koyyala V. P. B, Goyal S, Rajpurohit S, Sharma M, Jajodia A.Application of next-generation sequencing to detect targetable mutation: A case report of good response to everolimus in salivary ductal carcinoma. International Journal of Medical and Health Research. 2018;4:153-155.
  • Agrawal C, Sharma M, Singh A, Goyal V, Talwar V. Isolated splenic metastasis in a case of carcinoma jejunum. Indian Journal of Medical and Pediatric Oncology 2018 Accepted and ahead of print.
  • Sharma M. Rare case of non-small cell lung cancer with intracardiac metastasis.Accepted for print in the Indian Journal of Cardiology.
  • SharmaM. Primary squamous cell carcinoma of the stomach. 2018. Asian journal of oncology.
  • Sharma M. Excellent Outcome in a Patient with Choriocarcinoma with Spinal Metastasis with Cord Compression: September 2019:DOI:10.1007/s40944-019-0319-9.
  • Palliative chemotherapy in elderly patients with comorbidities: is it a paradox: May2019:Indian Journal of Palliative Care
  • A rare case of pinealoblastoma in an adult with complete response to treatment: October 2018: South Asian Journal of Cancer 7(4):262: DOI:10.4103/sajc.sajc_262_18.

    • Overview

  • Dr. Manish Sharma is a well-known doctor in the field of oncology. A beloved healthcare professional, he balances his state-of-the-art clinical skills with deep-mindedness toward patients. A career spanning over 20 years of patient care, with more than half that time dedicated to the domain of cancer therapy, has shaped him into one who combines an unusual set of skills with dogged determination to improve the quality of life of cancer patients. Currently, Dr. Sharma holds the position of Senior Consultant in Medical Oncology at Manipal Hospital, Delhi; he is reputed to be able to integrate state-of-the-art treatments with hands-on care, nurturing each patient with care.

  • His medical journey began at PGIMS, Rohtak, where he completed his graduation in medicine, followed by a DNB in Medicine from Safdarjung Hospital, New Delhi. His change of concentration to the field of cancer fuelled him towards super-specialisation in Medical Oncology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre (RGCI&RC), Delhi. He was awarded the coveted President NBE Super-Speciality Gold Medal, which goes to show that, apart from academic brilliance, he was dedicated to changing the fate of oncology care.

  • He has also held numerous prestigious leadership positions that have contributed to shaping his professional career as well as served numerous patients. As Consultant and Head of Unit, Medical Oncology at Action Cancer Hospital, Paschim Vihar, Delhi, and earlier as Consultant in Medical Oncology at RGCI&RC, he has played a leading role in defining cancer treatment protocols, mentoring younger doctors, and implementing new therapies. His work has spanned the management of solid tumours—including breast, lung, gastrointestinal, and genitourinary cancers—as well as haematological malignancies such as leukaemia, lymphoma, and myeloma. Whether it is targeted therapy, immuno‑oncology, or precision medicine, Dr. Sharma is adept at designing treatment plans that are uniquely tailored to the medical and emotional needs of each individual.

    • Fellowship & Membership

  • ASCO
  • ESMO
  • ISMPO
  • Preceptorship program on early breast cancer organised by Peter MacCallum center Melbourne, Australia.
  • Lung cancer preceptorship organised by Peter MacCallum Centre Melbourne, Australia.
  • Preceptorship course on immunoncology organised by ESMO. Singapore.
  • Receptorship course in immunooncology organised by ESMO. Singapore.
  • Advanced course in clinical questions in prostate cancer organised by ESMO. Singapore.
  • Preceptorship programme in NSCLC organised by ESMO. Singapore.
  • Medical Council of India, registration number 26551.

    • Field of Expertise

  • Chemotherapies
  • Immunotherapies
  • Targetted Theries
  • Precision Medicine
  • Hormonal Therapies
  • All Types Of Solid Tumours And Haematological Malignancies
  • Preventive And Palliative Care

    • Languages Spoken

  • English
  • Hindi
  • Punjabi

    • Awards & Achievements

  • President NBE gold medal award in medical oncology.
  • ANBAI Super Speciality Gold Medal Award 2017.

FAQ's

Patients visit Dr. Manish Sharma, a leading Consultant - Medical Oncology at Manipal Hospitals Dwarka - Delhi, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Manish Sharma is a trusted choice for exceptional medical support.

Home Delhi Doctors Dr-manish-sharma-medical-oncologist

Appointment
Health Check
Home Care
Contact Us
review icon
Review Us
Call Us